Palm Beach, FL –February 27, 2019 – The recent reports that projected the CBD markets will hit $22 billion by 2022 also predict that the world CBD markets could outpace marijuana… or recreational cannabis. This is not only good news for North American cannabis companies regarding domestic sales, but also for international sales. North American companies will become players in the worldwide import and export markets as well. A recent publication by an industry insider recently said: “The international Hemp import / export business while young, is poised to BOOM in the United States. At the present date, importation of Hemp products consists mostly of CBD isolate for two important reasons. The first reason is CBD isolate is a price dense product. When considering the S&H costs of moving a product, something of substantial size like biomass comes with logistical challenges. While biomass is generally is worth .10 – .20 cents per gram, CBD isolate market price is around $7.5/ gram, 50x more price dense per volume.” Active companies in the cannabis industry includes: CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTC:CRXPF), Aphria Inc. (NYSE: APHA) (TSX: APHA), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF), Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF).
The Kush article continued: “At the present date, importation of Hemp products consists mostly of CBD isolate (because) CBD isolate is a price dense product. When considering the S&H costs of moving a product, something of substantial size like biomass comes with logistical challenges. In the future, (they) believe that there will be two main markets for exportation, CBD isolate and CBD distillate due to the high value density of CBD. This is because the USA is poised to become an agricultural power in Hemp, and industrialization will create an opportunity for the USA to become a worldwide hub for CBD. While flower quality Hemp will still be an export, the size of this market will be substantially smaller.
CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTCPK:CRXPF) (Frankfurt: 2FR) BREAKING NEWS: CROP announced today it has entered into a purchase and sales agreement with World Farms Corp. to divest its interests in CROP Jamaica and XHemplar S.R.L in Italy for CAD$2,000,000 worth of equity in World Farms Corp.
CROP will be retained as advisors in relation to research and development in plant science. The investment comprises of 10,000,000 common shares in World Farms Corp (‘WFC’). and represents a 19% ownership interest in WFC for CROP. The XHemplar S.R.L joint venture facility covers 87,120 square feet. CROP and XHemplar have been working with Italian agencies to import new and unique, high CBD genetics that are expected to command premium prices.
CROP JAMAICA has a five-acre property for the cultivation and extraction of cannabis. The principal local partner is Greg Douglas. During April to November 2017, Douglas was seconded to Jamaica’s Cannabis Licensing Authority (CLA) as their CEO. While there he issued the first commercial licenses.
CROP CEO, Michael Yorke, stated: “CROP has divested itself of these two international operations so that management can remain entirely focused on the expanding US operations while retaining a passive but strategic investment in an internationaly focused player offering CROP shareholders additional exposure to WFC’s global growth. The company has invested approximately $100,000 between the two projects. This represents a 2,000% return on investment for CROP and its stakeholders.
“The passing of the US Farm Bill in December 2018 has been a total game changer in terms of the vast opportunities opening up right now in the US. We firmly believe in striking while the iron’s hot right now on our US doorstep while maintaining exposure to infantile global opportunities.” Read this full announcement and more news for CROP Infrastructure at: https://financialnewsmedia.com/news-crop/
Additional cannabis industry related developments from around the markets:
Aphria Inc. (NYSE: APHA) (TSX: APHA) On February 26, the company announced a worldwide license agreement with Manna Molecular Science, LLC (“Manna”), producers of state-of-the-art cannabis transdermal patches. Leveraging Manna’s established formulations, equipment and processes, Aphria will produce and sell patches containing cannabis oils for its established suite of medical and adult-use brands. “As we continue to expand its use from product to ingredient, we are excited to offer innovative new ways for consumers to interact with cannabis,” said Jakob Ripshtein, President of Aphria. “As a company at the forefront of cannabis innovation, Manna Molecular Science will be an important strategic partner for Aphria. Like us, they are committed to making safe, high-quality cannabis products available to a wide array of global consumers.”
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD.TO) (OTCQX: TGODF) recently provided a detailed update on its Jamaican partner Epican Medicinals Ltd. (“Epican”). In June 2018, TGOD purchased 49.18% interest in Epican, a fully integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. Significant progress has been made towards expanding cultivation, opening additional retail dispensaries, and establishing a leadership position in Jamaica’s robust medical cannabis market.
“We have made incredible progress in Jamaica over the past 8 months,” commented Brian Athaide, Director and CEO of TGOD. “We plan to continue opening stores throughout the country, increasing productive capacity, and expanding our leadership in Jamaica. As Trelawny comes online in phases, we will accelerate production to meet growing demand within Jamaica and export product through TGOD’s distribution channels in Mexico and beyond.”
OrganiGram Holdings Inc. (TSX-V: OGI) (OTCQX: OGRMF) recently announced it has signed a letter of intent with the Société québécoise du cannabis (SQDC). This agreement solidifies the Company’s position as a true national player in Canada’s legal adult use recreational cannabis marketplace. Organigram now has distribution in place for all ten Canadian provinces. “Organigram’s growth strategy has always focused on establishing a strong national footprint and building our brand presence with the Edison Cannabis line nationally,” says Greg Engel, Organigram’s Chief Executive Officer.
Namaste Technologies Inc. (TSXV: N.V) (OTCQB: NXTTF) recently announced that it has reached a mutually agreed upon settlement with Sean Dollinger resulting in Mr. Dollinger entering into an advisory relationship with Namaste providing transition support to the Company to ensure the best interests of the business and stakeholders are met (the “Agreement”). Pursuant to the Agreement, Mr. Dollinger has withdrawn his previously announced legal application against the Company and has agreed to step down from all formal roles with the Company, including as a director, which will also enable him to spend more time with his young family and pursue other opportunities. Meni Morim remains Interim Chief Executive Officer (“CEO”) of Namaste.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com (FNM) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press release issued above by CROP Infrastructure Corp. by a non affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact email: firstname.lastname@example.org – +1(561)325-8757